[ Price : $8.95]
FDA warns Newport Beach, CA-based physician Ehsan Sadri about failing to follow the investigational plan in two clinical trials.[ Price : $8.95]
FDA plans a two-day public workshop next month aimed at improving how pregnancy registries are designed and used to assess the saf...[ Price : $8.95]
Organogenesis says it has reached agreement with FDA that clears the way for a rolling BLA submission for its knee osteoarthritis ...[ Price : $8.95]
Three stakeholders express support for FDAs LEADER 3D rare disease educational materials and suggest ways to improve them.[ Price : $8.95]
FDAs just-released proposed fiscal year 2027 budget seeks a 3.3% increase or about $200 million to fund the agencys operations.[ Price : $8.95]
FDAs updated guidance on how patient preference information can be incorporated into regulatory decision-making for medical device...[ Price : $8.95]
Amgen reports positive topline results from a Phase 3 trial evaluating a subcutaneous version of its thyroid eye disease drug Tepe...[ Price : $8.95]
ImmunityBio says it has responded to FDAs recent Warning Letter on the companys alleged misleading promotional claims about its ca...